Gujarat Inject (Kerala) is currently trading at its upper circuit limit of Rs. 11.37, up by 0.54 points or 4.99% from its previous closing of Rs. 10.83 on the BSE.
The scrip opened at Rs. 10.29 and has touched a high and low of Rs. 11.37 and Rs. 10.29 respectively. So far 667307 shares were traded on the counter.
The BSE group 'XT' stock of face value Rs. 1 has touched a 52 week high of Rs. 14.30 on 09-Jul-2026 and a 52 week low of Rs. 1.90 on 24-Sep-2025.
Last one week high and low of the scrip stood at Rs. 13.95 and Rs. 10.29 respectively. The current market cap of the company is Rs. 166.56 crore.
The Non-Institutions held 100.00% stake in the company.
Gujarat Inject (Kerala) has entered into an agreement with Storenergy, a company incorporated in England, to work together as strategic business partners for pursuing Thermal Energy Storage System (TESS) opportunities in India. The arrangement is expected to facilitate the company’s participation in the TESS business and related opportunities in the Indian market.
Gujarat Inject (Kerala) is undergoing a strategic transformation with an increasing focus on renewable energy and solar solutions. The company has expanded its presence in Solar PV Modules and related clean energy businesses while continuing to strengthen operational capabilities, financial performance and long-term growth prospects.
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1928.00 |
| Dr. Reddys Labs. | 1170.40 |
| Cipla | 1414.35 |
| Lupin | 2141.25 |
| Zydus Lifesciences | 1166.60 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: